5F-ADB-PINACA Wikipedia - Versionsgeschichte

EdwinDesailly9 am 18. Juni 2026 um 07:19 Uhr

2026-06-18T07:19:24Z

BernieceFriend: Die Seite wurde neu angelegt: „Some mice showed abnormal behaviors (catalepsy, loss of traction, convulsion) right after the administration of the tested substances. The locomotor activity o…“

2026-05-23T07:35:47Z

Die Seite wurde neu angelegt: „Some mice showed abnormal behaviors (catalepsy, loss of traction, convulsion) right after the administration of the tested substances. The locomotor activity o…“

Neue Seite

Some mice showed abnormal behaviors (catalepsy, loss of traction, convulsion) right after the administration of the tested substances. The locomotor activity of the mice was measured 30 min and 2 hrs after the last substance administration. We also examined their neurotoxicity using brain samples through histopathological diagnose, especially in the nucleus accumbens core region. In histopathological analysis, neural cells of the animals treated with the high dose (5 mg/kg) of JWH-081 or JWH-210 showed distorted nuclei and nucleus membranes in the core shell of nucleus accumbens, suggesting neurotoxicity. Table of Conten After the incubation, mixture was centrifuged (18,000 x g, 20 °C) for 5 min and 0.5 μL of the supernatant was directly injected to the chromatographic system. In the next step, ammonium formate as salting agent was added to the mixture and incubated in a thermomixer (20 °C, 1200 rpm) for 15 min. After vortex-mixing, the mixture was allowed to stand click through the following document at room temperature for 5 min. MS/MS experiments were performed in MRM (multiple reaction monitoring) mode with an isolation window of 0.4 m/z. The MS measurement was performed in positive ion mode (except for some acidic compounds such as barbiturates Due to the unknown toxicity of newly emerging SCRAs, forensic assessments of cases involving these substances are challenging. According to the reported cases and reviews of the scientific literature, concurrent ethanol consumption should amplify the toxicity of SCRAs. The concentration of 4F-MDMB-BINACA in the postmortem blood was 2.50 and 2.34 ng/mL, and blood alcohol concentration was 2.11 and 2.49 g/L, respectively. Two fatal cases are reported caused by simultaneous consumption of 4F-MDMB-BINACA and ethanol. Fig. 2. 4F-MDMB-BINACA was hydrolysed via ester hydrolysis forming the 4F-MDMB-BINACA ester hydrolysis metabolite (B22). Data obtained from the twenty urine samples were retrospectively analysed and processed using TraceFinder software based on the identification criteria of mass errors less than ± 5 ppm for full MS peaks and MS/MS peaks from the theoretical mass and matching of MS/MS spectra. The mixture was vortex-mixed and 500 µL of this mixture and 500 µL of methanol were loaded onto the Clean Screen FASt® tube. After incubation, the mixture was cooled at room temperature, and 150 µL of purified water was added. High-resolution QTOF-MS data were acquired on an Agilent 6510 Accurate Mass QTOF mass spectrometer (Agilent Technologies) equipped with dual electrospray ionization (ESI) source operated in both positive and negative ion modes, to determine accurate masses of the metabolites. Chromatographic separation was performed on an Agilent 1290 LC system with a Poroshell 120 EC-C18 analytical column (2.7 μm, 75 × 2.1 mm; Agilent Technologies, Santa Clara, CA, USA). Fig. 1. Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, [https://cannabinoidsrc4f-adb.com/ click through the following document] liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can be estimated as a little ng/mL (0.37–4.1 ng/mL according to the reported cases) of SCRA and 1.5–2.5 g/L of ethanol. The reported cases and reviews of the scientific literature suggest a possible synergistic effect between SCRAs and ethanol, because their combined use clearly increases their toxicity. The victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi-organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic effect between THC and ethanol at low or moderate ethanol doses [29, 30], but no data on high doses of ethanol are available. Given that THC and ethanol act on the same receptors, data on their simultaneous use may yield important insights in this regard. Fungus C. elegans Methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB), found in numerous SCB product seizures, has been reported by various law enforcement since 2018 . However, most of the SCBs are full agonists at CB1 and CB2 receptors, having a higher risk of undesirable side effects when compared to THC which is a partial agonist . Synthetic cannabinoids (SCBs) are agonists at cannabinoid receptor type 1 (CB1) and type 2 (CB2), where they elicit their main effect Although there were reports on the metabolism of 4F-MDMB-BINACA using in-vivo and various in-vitro models, studies were either conducted using small in-vivo sample size such as 1 to 4 samples [5, 29] or in closed environments such as forensic psychiatric wards and prisons . The hepatic cell line HepG2 is often used as an initial screen as it is known to produce high reproducibility results with relatively stable enzyme concentration, although they are limited by the low-level expression of several metabolizing enzymes, including the cytochrome P450 (CYP) class of proteins [17, 18]. In-vitro metabolism studies are generally used to complement these data using perfused organs, tissue or cell cultures and microsomal preparations amongst which pooled human liver microsomes (HLM) have been frequently used to elucidate metabolism of SCBs [12,13,14,15,16]. Since most SCBs are found extensively in metabolized forms in urine, the identification of metabolites is of vital importance for forensic and clinical toxicologists. Identifying SCB intake and its correlating specific adverse effects require rapid elucidation of these SCBs. The proliferation of SCBs has become a global challenge as new compounds are rapidly introduced into the illegal drug market to evade existing drug laws. Fig.

← Nächstältere Version		Version vom 18. Juni 2026, 07:19 Uhr
Zeile 1:		Zeile 1:
−	~~Some~~ mice ~~showed abnormal behaviors~~ (~~catalepsy~~, ~~loss of traction~~, ~~convulsion~~) ~~right after the administration~~ of the ~~tested~~ substances. The locomotor activity of the mice ~~was measured 30~~ min ~~and 2 hrs after~~ the ~~last substance administration~~. ~~We also examined their neurotoxicity~~ using ~~brain samples through histopathological diagnose~~, ~~especially~~ in the ~~nucleus accumbens core region~~. In ~~histopathological analysis~~, ~~neural cells~~ of ~~the animals~~ treated with ~~the high dose~~ (5 mg/kg) ~~of JWH-081~~ or ~~JWH-210 showed distorted nuclei and nucleus membranes in~~ the ~~core shell~~ of ~~nucleus accumbens~~, ~~suggesting neurotoxicity~~.~~<br>Table of Conten~~<br><br><br>After the incubation, mixture was centrifuged (18,000 x g, 20 °C) for 5 min and 0.5 μL of the supernatant was directly injected to the chromatographic system. In the next step, ammonium formate as salting agent was added to the mixture and incubated in a thermomixer (20 °C, 1200 rpm) for 15 min. After vortex-mixing, the mixture was allowed to stand ~~click through the following document~~ at room temperature for 5 min. MS/MS experiments were performed in MRM (multiple reaction monitoring) mode with an isolation window of 0.4 m/z. The MS measurement was performed in positive ion mode (except for some acidic compounds such as barbiturates<br><br><br>~~Due to the unknown toxicity~~ of newly emerging SCRAs, forensic assessments of cases involving these substances are challenging. According to the reported cases and reviews of the scientific literature, concurrent ethanol consumption should amplify the toxicity of SCRAs. The concentration of 4F-MDMB-BINACA in the postmortem blood was 2.~~50 and 2.34 ng/mL~~, ~~and blood alcohol concentration was 2~~.~~11 and 2~~.~~49 g/L, respectively. Two fatal cases are reported caused~~ by ~~simultaneous consumption of 4F~~-~~MDMB-BINACA and ethanol.<br>Fig. 2. <br>4F-MDMB-BINACA was hydrolysed via ester hydrolysis forming the 4F-MDMB-BINACA ester hydrolysis metabolite~~ (~~B22~~). ~~Data obtained from~~ the ~~twenty urine samples~~ were ~~retrospectively analysed and processed using TraceFinder software based on the identification criteria~~ of ~~mass errors less than ± 5 ppm for full MS peaks and MS/MS peaks from the theoretical mass and matching of MS/MS spectra. The mixture was vortex~~-~~mixed and 500 µL of this mixture and 500 µL of methanol were loaded onto the Clean Screen FASt® tube. After incubation, the mixture was cooled at room temperature~~, and ~~150 µL~~ of ~~purified water was added~~. ~~High-resolution QTOF-MS data were acquired on an Agilent 6510 Accurate Mass QTOF mass spectrometer~~ (~~Agilent Technologies~~) ~~equipped with dual electrospray ionization~~ (~~ESI~~) ~~source operated~~ in ~~both positive~~ and ~~negative ion modes, to determine accurate masses of the metabolites. Chromatographic separation was performed on an Agilent 1290 LC system~~ with ~~a Poroshell 120 EC~~-~~C18 analytical column~~ (~~2.7 μm, 75 × 2.1 mm; Agilent Technologies, Santa Clara, CA, USA~~)~~.<br>Fig. 1. <br>Monitoring metabolism~~ of ~~synthetic cannabinoid~~ 4F-MDMB-BINACA ~~via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, [https://cannabinoidsrc4f-adb~~.~~com/ click through the following document] liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can be estimated as a little ng/mL~~ (0.~~37–4~~.~~1 ng/mL according to the reported cases~~) ~~of SCRA~~ and 1.~~5–2~~.~~5 g/L of ethanol~~. ~~The reported cases and reviews of the scientific literature suggest a possible synergistic effect between SCRAs and ethanol~~, ~~because their combined use clearly increases their toxicity. The victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi~~-~~organ failure 11 days after hospital admission~~ . ~~Studies have found no unequivocal synergistic effect between THC and ethanol at low or moderate ethanol doses [29~~, ~~30]~~, ~~but no data on high doses of ethanol are available. Given that THC and ethanol act on the same receptors, data on their simultaneous use may yield important insights in this regard.~~<br>~~Fungus C. elegans~~ <br>Methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB), found in numerous SCB product seizures, has been reported by various law enforcement since 2018 . However, most of the ~~SCBs are full agonists at CB1 and CB2 receptors, having~~ a ~~higher risk of undesirable side effects when compared~~ to ~~THC which is a partial agonist . Synthetic cannabinoids (SCBs) are agonists at cannabinoid receptor type 1 (CB1) and type 2 (CB2)~~, ~~where they elicit their main effect~~<br><br><br>~~Although there were reports on the metabolism~~ of ~~4F-MDMB-BINACA using in-vivo and various in-vitro models~~, ~~studies were either conducted using small in-vivo sample size such as 1 to 4 samples [5, 29] or in closed environments such as forensic psychiatric wards and prisons~~ . ~~The hepatic cell line HepG2 is often used as an initial screen as it is known to produce high reproducibility results with relatively stable enzyme concentration~~, ~~although they are limited by the low-level expression~~ of ~~several metabolizing enzymes, including~~ the ~~cytochrome P450 (CYP) class~~ of ~~proteins [17, 18]. In-vitro metabolism studies~~ are ~~generally used~~ to ~~complement these data using perfused organs, tissue or cell cultures~~ and ~~microsomal preparations amongst which pooled human liver microsomes~~ (~~HLM~~) ~~have been frequently used to elucidate metabolism of SCBs [12,13,14,15,16]~~. ~~Since most SCBs are found extensively in metabolized forms in urine,~~ the ~~identification of metabolites~~ is of ~~vital importance for forensic and clinical toxicologists. Identifying SCB intake and its correlating specific adverse~~ effects ~~require rapid elucidation of these SCBs~~. ~~The proliferation~~ of ~~SCBs has become a global challenge as new compounds~~ are ~~rapidly introduced into~~ the ~~illegal drug market to evade existing drug laws.<br>Fig.~~	+	In both tests, a group of mice were treated with negative control (vehicle, 1 mg/kg, i.p.), positive control (methamphetamine, 1 mg/kg, i.p.), or one of the three doses of test substances (0.1, 1, 5 mg/kg, i.p.) once every other day for 10 day<br><br><br>Synthetic cannabinoids have consistently been shown to produce discriminative stimulus effects similar to those [https://cannabinoidsrc4f-adb.com/ 4F ADB] of Δ9-THC (Bannister and Connor, 2018), and MDMB-FUBINACA fully substituted for Δ9-THC (Gamage et al., 2018). The chemical structures of the recent synthetic cannabinoids are unlike that of Δ9-THC, but are largely based on the structure of older synthetic cannabinoids that are known to have substantial abuse liability (Fig. 1). All 5 compounds decreased locomotor activity and produced discriminative stimulus effects similar to those of Δ9-THC, which suggests they may have abuse liability similar to that of Δ9-THC. Subsequent testing identified 5F-ADB to have been present in a total of ten people who had died from unexplained drug overdoses in Japan between September 2014 and December 2014. AMB-FUBINACA produced tremors and may be of increased risk in human recreational users.<br>Michael B Gatch <br>These findings are in agreement with earlier studies showing the synthetic cannabinoids substitute for the discriminative stimulus effects of Δ9-THC (see review by Wiley et al., 2017). Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. As mentioned previously, short-onset compounds have a greater abuse liability; further, compounds that have fewer adverse effects while they are active are likely to be preferred. All five of the compounds in the present study fully substituted with a pretreatment time of 15 min, suggesting a rapid onset of the discriminative stimulus effects. All of the cathinones fully substituted for the discriminative stimulus effects of Δ9-tetrahydrocannabinol (≥80% drug-appropriate responding). Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun<br><br><br>To evaluate whether the changes of coordinative functions by CNS damages were due to test substances, rota-rod test was performed using Rota-rod apparatus (Daejong, Seoul, Korea). The test apparatus for the locomotor activity test was designed to measure locomotor activity automatically using UV system (AM 1051, Benwick Electronics, Benwick, UK) when experimental animals moved in the chamber. In both tests, a group of mice were treated with negative control (vehicle, 1 mg/kg, i.p.), positive control (methamphetamine, 1 mg/kg, i.p.), or one of the three doses of test substances (0.1, 1, 5 mg/kg, i.p.) once every other day for 10 day<br><br><br>After the incubation, mixture was centrifuged (18,000 x g, 20 °C) for 5 min and 0.5 μL of the supernatant was directly injected to the chromatographic system. In the next step, ammonium formate as salting agent was added to the mixture and incubated in a thermomixer (20 °C, 1200 rpm) for 15 min. After vortex-mixing, the mixture was allowed to stand 4F ADB at room temperature for 5 min. MS/MS experiments were performed in MRM (multiple reaction monitoring) mode with an isolation window of 0.4 m/z. The MS measurement was performed in positive ion mode (except for some acidic compounds such as barbiturates<br><br><br>Separation of compounds was performed on a 2.1 mm×100 mm, 1.7 4F ADB μm particle size ACQUITY Torus™ DIOL analytical column (Waters) with guard cartridge. Measurements were performed by an ACQUITY UPC2 supercritical fluid chromatography system (Waters) coupled with a Xevo TQ-S Triple Quadrupole Mass Spectrometer (Waters). During the death scene examination, multiple cigarette butts without filters were found in an ashtray; also found were alcohol bottles, an unopened box of nebivolol-containing drug, and 18 g of unrecognizable herbal residue in a cigarette box.<br>Victim B also brought "something resembling a drug" (unrecognizable by Witness A) from his cousin (Witness B) in a cigarette box and mixed this substance with their tobacco. The half-maximal effective concentration (EC50) of 4F-MDMB-BINACA is 5.69 nM (2.76–11.0 nM) on CB1, and 0.69 nM (0.30–1.56 nM) on CB2, in vitro half-life (t1/2) is 10.27 min . It is usually available as a powder, liquid (vapor fluid), or herbal plant mixtur<br><br>55 % of the patients required a longer admission due to symptoms such as severe tachycardia, hypertensive crise, convulsions, acute kidney insufficiency but also long-lasting, severe psychological problems<br><br><br>Acute kidney damage and even kidney failure have been reported following use of synthetic cannabinoids (Davidson, et al., 2017). One recent study has looked at other mechanisms of action in some of the older synthetic cannabinoids and reported that some produced varying amounts of activity at sites which are related to cardiotoxicity and heart disease (Wiley et al., 2016). It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids produce effects at other receptors. A major cause of concern is that some of the more recently seen synthetic cannabinoids are more likely to produce extremely toxic effects than the older synthetics (Tai and Fantegrossi, 2017